CD8A and neoplasm: The findings revealed that cGAMP activated innate and cross-primed adaptive immunity, increased and enhanced antigen-presenting activity of DCs, and activated CD8+T cells to effectively destroy tumours and reversed inhibitory immune microenvironment.